Bayhill Therapeutics
Latest round
- Series C
Last raised
- Jul 2009
Total raised
- $51M
Investors
- 14
About Bayhill Therapeutics
Bayhill Therapeutics is a US-based bio-pharmaceutical company that operates as a developer of therapeutics for autoimmune diseases.
Who invested in Bayhill Therapeutics
14 investors across 3 rounds
See all investors in Bayhill Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bayhill Therapeutics
Who invested in Bayhill Therapeutics?
Bayhill Therapeutics has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bayhill Therapeutics raised?
Bayhill Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Bayhill Therapeutics last raise money?
Bayhill Therapeutics's most recent round on record is a Series C, in Jul 2009.
What does Bayhill Therapeutics do?
Bayhill Therapeutics is a US-based bio-pharmaceutical company that operates as a developer of therapeutics for autoimmune diseases.
Where is Bayhill Therapeutics headquartered?
Bayhill Therapeutics is headquartered in Palo Alto, US.
Which VCs invest in companies like Bayhill Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Bayhill Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Bayhill Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.